Literature DB >> 2849640

Antitumor agents, 99. Synthetic ring C aromatized podophyllotoxin analogues as potential inhibitors of human DNA topoisomerase II.

S A Beers1, Y Imakura, H J Dai, D H Li, Y C Cheng, K H Lee.   

Abstract

Several ring C aromatized analogues of podophyllotoxin were synthesized for testing against human DNA topoisomerase II. The results indicate that aromatization of ring C gave rise to no inhibition of this enzyme at 200 microM. A comparison of the cytotoxicity among these compounds also demonstrates that a free hydroxyl group at C-4 contributes to significant cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2849640     DOI: 10.1021/np50059a014

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  5 in total

1.  Antitumor agents. 126. Novel 4 beta-substituted anilino derivatives of 3',4'-O,O-didemethylpodophyllotoxin as potent inhibitors of human DNA topoisomerase II.

Authors:  Z Q Wang; Y C Shen; H X Chen; J Y Chang; X Guo; Y C Cheng; K H Lee
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

Review 2.  Podophyllotoxin: History, Recent Advances and Future Prospects.

Authors:  Zinnia Shah; Umar Farooq Gohar; Iffat Jamshed; Aamir Mushtaq; Hamid Mukhtar; Muhammad Zia-Ui-Haq; Sebastian Ionut Toma; Rosana Manea; Marius Moga; Bianca Popovici
Journal:  Biomolecules       Date:  2021-04-19

3.  Podophyllin in Dermatology: Revisiting a Historical Drug.

Authors:  Ajeet Singh; Ritul Choudhary; Satyaki Ganguly
Journal:  Indian Dermatol Online J       Date:  2022-01-24

4.  Novel DNA topoisomerase IIα inhibitors from combined ligand- and structure-based virtual screening.

Authors:  Malgorzata N Drwal; Jessica Marinello; Stefano G Manzo; Laurence P G Wakelin; Giovanni Capranico; Renate Griffith
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

Review 5.  In vivo optical molecular imaging of inflammation and immunity.

Authors:  Nian Liu; Xiao Chen; Melanie A Kimm; Matthias Stechele; Xueli Chen; Zhimin Zhang; Moritz Wildgruber; Xiaopeng Ma
Journal:  J Mol Med (Berl)       Date:  2021-07-17       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.